valproate
Selected indexed studies
- Valproate-associated hair abnormalities: Pathophysiology and management strategies. (Hum Psychopharmacol, 2022) [PMID:34532891]
- Valproate, divalproex, valpromide: Are the differences in indications justified? (Biomed Pharmacother, 2023) [PMID:36521249]
- Valproate-Autism Labyrinth. (Psychopharmacol Bull, 2024) [PMID:39263199]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Valproate-associated hair abnormalities: Pathophysiology and management strategies. (2022) pubmed
- Valproate, divalproex, valpromide: Are the differences in indications justified? (2023) pubmed
- Valproate-Autism Labyrinth. (2024) pubmed
- Clinical and pathophysiological characteristics of valproate-induced pleural effusion. (2021) pubmed
- [Valproate in the treatment of epilepsy and status epilepticus]. (2017) pubmed
- Sodium Valproate-Induced Hyperpigmentation. (2023) pubmed
- Relevance of CYP2C9 Function in Valproate Therapy. (2019) pubmed
- Sodium valproate. (1988) pubmed
- Sodium valproate. (1980) pubmed
- Sodium valproate's uncharted role in neuroprotection and neurotoxicity-A literature review. (2025) pubmed